Edition:
United Kingdom

Deciphera Pharmaceuticals Inc (DCPH.OQ)

DCPH.OQ on NASDAQ Stock Exchange Global Select Market

23.94USD
22 Mar 2019
Change (% chg)

$-0.52 (-2.13%)
Prev Close
$24.46
Open
$24.28
Day's High
$24.58
Day's Low
$23.65
Volume
79,109
Avg. Vol
82,188
52-wk High
$45.61
52-wk Low
$18.56

Chart for

About

Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing drugs to improve the lives of cancer patients. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib. Its proprietary kinase switch control inhibitor platform, inhibit the activation of kinases. DCC-2618, an orally... (more)

Overall

Beta: --
Market Cap(Mil.): $702.77
Shares Outstanding(Mil.): 30.68
Dividend: --
Yield (%): --

Financials

  DCPH.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -1.08 -- --
ROI: -- 8.89 13.82
ROE: -- 10.02 15.24

Earnings vs. Estimates